Tolerability of the Immersive Virtual Reality System Grail in Subjects Affected by Rett Syndrome
NCT ID: NCT05691582
Last Updated: 2023-01-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
9 participants
INTERVENTIONAL
2021-07-01
2022-04-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
1. Grail environment (training in dark conditions, interaction with wide and surrounding screen, positioning over the treadmill);
2. time to prepare a set of body marker in order to execute a gait analysis;
3. walking activity over treadmill, with immersive virtual reality;
4. proprioceptive stimulatione provided by the GRAIL platform;
5. cognitive-attentive span time to the activity proposed. The secondary goal is to understand if a training that avail of treadmill and virtual reality would be useful in the future in improving gait characteristics in subjects affected by Rett syndrome
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Sensorimotor Exercises in Virtual Reality Platform in Individuals With Human T-lymphotropic Virus
NCT02877030
Immersive Virtual Reality for Visuo-motor Integration Skill Assessment
NCT04612049
Validating Innovative Biosensors for Rett Autonomic Symptom Tracking
NCT06338267
Virtual Reality in Children With and Without Vestibular Deficits
NCT04791748
Binocular Dig Rush Game Treatment for Amblyopia
NCT02983552
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
DEVICE_FEASIBILITY
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Single arm
All the subjects recruited have 4 access to GRAIL, in 4 different day, to test their tolerability to the proposals
GRAIL
The subjects experiment GRAIL virtual reality for three days, during which they deal with 4 different activities.
In the first activity subjects are required to ask over the treadmill in a snow environment.
in the second they are required to stand over the moving platform in a simulation of a boat pitch.
in the third they have to walk over a bridge with a slope. in the fourth the subjects are required to try so interact with virtual reality and to ski between snowman.
if it is possible, on the last day a gait analysis is executed
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
GRAIL
The subjects experiment GRAIL virtual reality for three days, during which they deal with 4 different activities.
In the first activity subjects are required to ask over the treadmill in a snow environment.
in the second they are required to stand over the moving platform in a simulation of a boat pitch.
in the third they have to walk over a bridge with a slope. in the fourth the subjects are required to try so interact with virtual reality and to ski between snowman.
if it is possible, on the last day a gait analysis is executed
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
6 Years
35 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Associazione Italiana Rett (AIRett) O.n.l.u.s.
UNKNOWN
IRCCS Eugenio Medea
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
IRCCS E. Medea
Bosisio Parini, Lecco, Italy
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
885
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.